|Go to market news section|
The Board of Renishaw plc is pleased to announce the appointment of John Jeans CBE CEng as a non-executive director with effect from 11 April 2013.
In an industrial career spanning more than 35 years, John (age 63) held senior leadership positions in several global companies including Smith & Nephew, Bristol Myers Squibb, Johnson & Johnson and Amersham plc (now GE Healthcare). His experience ranges from medical devices and pharmaceuticals to in-vivo and in-vitro diagnostics encompassing research, product development, manufacturing and commercialisation.
John is currently Chairman of the Council of Cardiff University and Imanova (an imaging research partnership between three London Universities and the Medical Research Council). In addition he chairs the Board of MRC Technology and is a non executive Director of the Alliance Medical Group. He is also a Board member of the University and College Employers Association.
As an advisor to several public sector organizations, John currently Chairs the Technology Strategy Board's stratified medicine advisory Board, is a Steering Board member of the HealthTech and Medicines Knowledge Transfer Network and an advisor to the University of Manchester's venture fund.
John will also become a member of Renishaw plc's Audit Committee, Remuneration Committee and Nomination Committee.
There is no information to be disclosed for the purposes of Listing Rule 9.6.13. John does not currently hold any shares in the Company.
Commenting on the changes to the Board, Sir David McMurtry CBE RDI FRS FREng CEng FIMechE, Chairman and Chief Executive, said:
"I am delighted to welcome John to the Board. With his extensive experience in the healthcare industry and in engineering technologies John will be a valuable addition to the Company's resources at board level"
11 April 2013
Registered number: 01106260
Registered office: New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR
For further details contact:
Tel: 01453 524524
|London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.|
|©London Stock Exchange plc. All rights reserved|